The Science of Parkinson's 1 / 3
Researchers present a second-generation “hypoxia in a pill” (combining a hemoglobin affinity enhancer to limit oxygen delivery with a HIF-2α inhibitor) intervention that rescues neurodegen. phenotypes across different mouse models, including #Parkinsons www.pnas.org/doi/10.1073/...